Evaluation of Probiotics' Effect on Atrial Fibrillation Recurrence in Patients Undergoing Cardioversion

Starting soon · Not applicable

Conditions studied: Atrial Fibrillation (AF)

In brief

The aim of this clinical study is to evaluate the efficacy and tolerability of probiotics on atrial fibrillation recurrence.

Key facts

Study ID

NCT07568964

Run by

Ain Shams University

People needed

56

Starts

2026-05-10

Expected to finish

2027-09-01

Last updated by the study team

2026-05-06

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Female or male aged 40 years or above with BMI less than 40
• Persistent AF patients directly after cardioversion

You may not qualify if…

• History of probiotic supplementation in the previous 6 weeks
• Autoimmune diseases
• Ongoing treatment with immunosuppressive therapies
• Active Infection
• Pregnant or breast-feeding patients
• Active participation in another clinical study
• History of or known allergy or intolerability to the study medications

Where it is running

• Ain Shams University's Hospital — Cairo, Egypt

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.